Электронная библиотека Финансового университета

     
?

Детальная информация
Карточка Таблица RUSMARC

Laboratory diagnostic pathways: clinical manual of screening methods and stepwise diagnosis / Walter Hofmann, Johannes Aufenanger, Georg Hoffmann (eds.) ; translated by Martin Schlecht. — 2nd updated and expanded edition. — 1 online resource (232 pages) — <URL:http://elib.fa.ru/ebsco/1354462.pdf>.

Дата создания записи: 24.09.2016

Тематика: Diagnosis, Differential.; HEALTH & FITNESS / Diseases / General; MEDICAL / Clinical Medicine; MEDICAL / Diseases; MEDICAL / Evidence-Based Medicine; MEDICAL / Internal Medicine

Коллекции: EBSCO

Разрешенные действия: –

Действие 'Прочитать' будет доступно, если вы выполните вход в систему или будете работать с сайтом на компьютере в другой сети Действие 'Загрузить' будет доступно, если вы выполните вход в систему или будете работать с сайтом на компьютере в другой сети

Группа: Анонимные пользователи

Сеть: Интернет

Права на использование объекта хранения

Место доступа Группа пользователей Действие
Локальная сеть Финуниверситета Все Прочитать Печать Загрузить
Интернет Читатели Прочитать Печать
-> Интернет Анонимные пользователи

Оглавление

  • Contents
  • List of Authors
  • I General Information
    • 1 Introduction
      • 1.1 Definitions
        • 1.1.1 Legal Rulings
      • 1.2 Historical Development
      • 1.3 Diagnostic Strategies
        • 1.3.1 Stepwise Diagnosis or Profile Diagnosis
        • 1.3.2 Diagnostic Quality Criteria
        • 1.3.3 Stepwise Diagnosis during Screening of Clinically Unremarkable Persons
      • 1.4 Outlook
    • 2 Implementation
      • 2.1 Organizational Requirements in the Hospital
      • 2.2 Economic Impacts
      • 2.3 Implementation of Information Technology
  • II Specialist Section
    • 3 Practical Examples for Screening Examinations
      • 3.1 Internist Admissions Screening
      • 3.2 Acute Poisoning
        • 3.2.1 Acute Drug Intoxication
          • 3.2.1.1 Forms and Origins of Acute Drug Intoxication
        • 3.2.2 Toxidromes
          • 3.2.2.1 Anticholinergic Toxidrome
          • 3.2.2.2 Cholinergic Toxidrome
          • 3.2.2.3 Hallucinogenic Toxidrome
          • 3.2.2.4 Opiate/Opioid Toxidrome
          • 3.2.2.5 Sedative/Hypnotic Toxidrome
          • 3.2.2.6 Sympathomimetic Toxidrome
        • 3.2.3 Acute Poisoning of Unknown Origin
          • 3.2.3.1 Forms and Origins of Acute Poisoning of Unknown Origin
          • 3.2.3.2 Decision Tree for Acute Poisoning of Unknown Origin
      • 3.3 Extravascular Fluids
        • 3.3.1 Cerebrospinal Fluid Fistula Diagnostics
        • 3.3.2 Peritoneal Dialysis Diagnostics
        • 3.3.3 Chyle Diagnostics
        • 3.3.4 Urine Leakage Diagnostics
        • 3.3.5 Effusion Diagnostics
          • 3.3.5.1 Ascites
          • 3.3.5.2 Pleural Effusion
          • 3.3.5.3 Pericardial Effusion
    • 4 Practical Examples of Targeted Stepwise Diagnosis
      • 4.1 Endocrinology
        • 4.1.1 Thyroid Gland
          • 4.1.1.1 Hyperthyroidism
          • 4.1.1.2 Hypothyroidism
          • 4.1.1.3 Pre- and Post-analytical Principles
          • 4.1.1.4 Laboratory Analysis
        • 4.1.2 Adrenal Glands
          • 4.1.2.1 Cushing Syndrome
          • 4.1.2.2 Clarification of Cushing Syndrome
          • 4.1.2.3 Hypocortisolism
      • 4.2 Diabetes and Metabolism
        • 4.2.1 Diabetes Mellitus
          • 4.2.1.1 Diagnosis and Risk Assessment
          • 4.2.1.2 Gestational Diabetes Mellitus (GDM)
          • 4.2.1.3 Monitoring Diabetes Mellitus
        • 4.2.2 Lipid and Lipoprotein Metabolism
          • 4.2.2.1 Assessment of Cardiovascular Risk
          • 4.2.2.2 Differential Diagnosis of Lipid Metabolism Disorders
        • 4.2.3 Porphyrias
          • 4.2.3.1 Neurovisceral Attacks
          • 4.2.3.2 Photodermatoses
      • 4.3 Liver and Pancreatic Disorders
        • 4.3.1 Hepatobiliary Disorders
          • 4.3.1.1 Non-Alcoholic Fatty Liver Disease (NAFLD)
          • 4.3.1.2 Acute Viral Hepatitis
          • 4.3.1.3 Jaundice
        • 4.3.2 Pancreatic Diseases
          • 4.3.2.1 Acute Pancreatitis
          • 4.3.2.2 Chronic Pancreatitis
      • 4.4 Kidneys and Efferent Urinary Tract
        • 4.4.1 Ruling Out Disorders of the Kidneys and Efferent Urinary Tract
          • 4.4.1.1 Medical History and Clinical Picture
          • 4.4.1.2 Pre- and Post-analytical Principles of Laboratory Diagnost ics
          • 4.4.1.3 Basic Diagnostics
          • 4.4.1.4 Analysis
        • 4.4.2 Stepwise Diagnostics of the Glomerular Filtration Rate
          • 4.4.2.1 Stages of Chronic Renal failure
          • 4.4.2.2 Analysis and Calculation of the Glomerular Filtration Rate
        • 4.4.3 Stepwise Diagnostics of Proteinuria
          • 4.4.3.1 Forms of Proteinuria
          • 4.4.3.2 Decision Tree for Proteinuria
          • 4.4.3.3 Quantification of Proteinuria
          • 4.4.3.4 Further Diagnostics
          • 4.4.3.5 Biomarkers and Proteomics
        • 4.4.4 Stepwise Diagnostics of Hematuria
          • 4.4.4.1 Decision Tree for Hematuria
        • 4.4.5 Stepwise Diagnostics of Leukocyturia
          • 4.4.5.1 Decision Tree for Leukocyturia
          • 4.4.5.2 Further Diagnostics
          • 4.4.5.3 Tubulointerstitial Kidney Disorders
        • 4.4.6 Implementation of the Diagnostic Pathways in a Hospital and Laboratory Information System (HIS, LIS)
      • 4.5 Hematology – Introduction and Overview
        • 4.5.1 General Hematology
          • 4.5.1.1 Erythropoiesis
          • 4.5.1.2 Megakariopoiesis – Thrombopoiesis
          • 4.5.1.3 Leukopoiesis – Generation of Myeloid Cell Lines
          • 4.5.1.4 Lymphopoiesis
          • 4.5.1.5 Hematopoiesis Disorders
        • 4.5.2 Specialized Hematology – Pathologies, Disorders, Diagnosis, Differentiation
          • 4.5.2.1 Anemia
          • 4.5.2.2 Eosinophilia
          • 4.5.2.3 Hemolysis
          • 4.5.2.4 Monoclonal Gammopathy
          • 4.5.2.5 Leukocytosis
          • 4.5.2.6 Lymphocytosis
          • 4.5.2.7 Neutropenia
          • 4.5.2.8 Pancytopenia
          • 4.5.2.9 Polycythemia
      • 4.6 Coagulation disorders
        • 4.6.1 Diagnostic Pathways for Coagulation disorders
          • 4.6.1.1 Isolated aPTT Prolongation
          • 4.6.1.2 Isolated Quick Time Reduction
          • 4.6.1.3 Bleeding Diathesis
          • 4.6.1.4 Acute Venous Thromboembolism
          • 4.6.1.5 Heparin-induced Thrombocytopenia (Type 2 HIT)
          • 4.6.1.6 Thrombophilia
      • 4.7 Neurological Disorders
        • 4.7.1 Neurological Laboratory Diagnostics
          • 4.7.1.1 Characteristics of Neurological Laboratory Diagnostics
          • 4.7.1.2 Cerebrospinal Fluid Diagnostic Parameters
          • 4.7.1.3 Pre-analytics in Cerebrospinal Fluid Diagnostics
        • 4.7.2 Diagnostic Pathways and Procedures
          • 4.7.2.1 Clinical Spectrum and Underlying Guidelines from Clinical Professional Associations
          • 4.7.2.2 Acute Meningitis
          • 4.7.2.3 Opportunistic CNS Infections
          • 4.7.2.4 Suspected SAH/Bloody Cerebrospinal Fluid
          • 4.7.2.5 Radicular Syndromes
          • 4.7.2.6 Meningeal carcinomatosis
          • 4.7.2.7 Chronic Inflammatory CNS Disorders
          • 4.7.2.8 Inflammatory Cerebrospinal Fluid Syndrome of Unknown Origin
          • 4.7.2.9 Dementia Syndromes
          • 4.7.2.10 Wilson’s disease
        • 4.7.3 Authors and Working Group
          • 4.7.3.1 Spokesperson for the Working Group
          • 4.7.3.2 Members of the Working Group
          • 4.7.3.3 Objective of the Neurology Working Group
      • 4.8 Autoimmune disorders
        • 4.8.1 Rheumatoid Arthritis Diagnostics
          • 4.8.1.1 Diagnostic Scheme
          • 4.8.1.2 Additional Reflections on Differential Diagnosis
        • 4.8.2 Systemic Lupus Erythematosus
          • 4.8.2.1 Laboratory Diagnostics
          • 4.8.2.2 Reflections on Differential Diagnosis
      • 4.9 Allergy Diagnostics – Diagnostic Pathways
        • 4.9.1 Food Allergy Diagnostics
        • 4.9.2 Inhalation Allergy Diagnostics
        • 4.9.3 Insect Venom Allergy Diagnostics
        • 4.9.4 Drug Allergy Diagnostics
      • 4.10 Ejaculate Analysis and Quality Assurance in Male Fertility Laboratories
        • 4.10.1 Introduction
        • 4.10.2 Pre-analytics and Macroscopic Physical Examination of Ejaculate
        • 4.10.3 Microscopic Examination of Ejaculate
        • 4.10.4 Further Biochemical Testing of Ejaculate
        • 4.10.5 Quality Assurance in Ejaculate Analysis
  • Index

Статистика использования

stat Количество обращений: 0
За последние 30 дней: 0
Подробная статистика